Zeo ScientifiX (ZEOX) Asset Writedowns and Impairment (2016 - 2023)
Zeo ScientifiX (ZEOX) posted quarterly Asset Writedowns and Impairment of $13000.0 for Q4 2023, up 74.38% year-over-year from $7455.0 in Q4 2022, and down 75.47% quarter-over-quarter from $53000.0 in Q3 2023.
Zeo ScientifiX (ZEOX) Asset Writedowns and Impairment (2016 - 2023) Analysis & Trends
Zeo ScientifiX's Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at $13000.0 for Q4 2023.
- In Q4 2023, Asset Writedowns and Impairment rose 74.38% year-over-year to $13000.0; the TTM figure through Oct 2023 stood at $84090.0 (up 364.84% YoY), while the FY2024 annual figure was $9000.0, down 93.66% from the prior year.
- Asset Writedowns and Impairment for Q4 2023 stood at $13000.0, down from $53000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $53000.0 in Q3 2023, with the low at $7455.0 in Q4 2022.
- The 3-year median for Asset Writedowns and Impairment is $11817.5 (2019), against an average of $21022.5.
- The sharpest annual moves came in 2019 and 2023: Asset Writedowns and Impairment slumped 59.33% in 2019, then surged 74.38% in 2023.
- Zeo ScientifiX's Asset Writedowns and Impairment stood at $10635.0 in 2019, then decreased by 29.9% to $7455.0 in 2022, then soared by 74.38% to $13000.0 in 2023.
- Business Quant data shows ZEOX's Asset Writedowns and Impairment at $13000.0 in Q4 2023, $53000.0 in Q3 2023, and $7455.0 in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | 13,000.00 |
| Oct 31, 2023 | 13,000.00 |
| Jul 31, 2023 | 53,000.00 |
| Jul 31, 2023 | 53,000.00 |
| Oct 31, 2022 | 7,455.00 |
| Oct 31, 2022 | 7,455.00 |
| Oct 31, 2019 | 10,635.00 |
| Oct 31, 2019 | 10,635.00 |
| Oct 31, 2018 | 26,150.00 |
| Oct 31, 2018 | 26,150.00 |
| Apr 30, 2018 | 1,822.00 |
| Apr 30, 2018 | 1,822.00 |
| Jan 31, 2018 | 34,268.00 |
| Jan 31, 2018 | 34,268.00 |
| Oct 31, 2017 | 5,250.00 |
| Oct 31, 2017 | 5,250.00 |
| Oct 31, 2016 | -4,963.00 |
| Oct 31, 2016 | -4,963.00 |
| Jan 31, 2016 | 5,463.00 |
| Jan 31, 2016 | 5,463.00 |